A PanCancer Atlas cohort of 494 prostate adenocarcinoma patients [21] revealed a positive correlation between MIR100HG and TGFB1 expression (Fig. 8a), and even stronger correlation between MIR100HG and TGFBI expression (Fig. 8b). Here, TGFBI is linked to prostate adenocarcinoma.